Jonathan Wolleben

Stock Analyst at Citizens JMP

(4.91)
# 254
Out of 5,134 analysts
700
Total ratings
52.2%
Success rate
22.1%
Average return

Stocks Rated by Jonathan Wolleben

Kalaris Therapeutics
Nov 12, 2026
Maintained: Buy
Price Target: $25 → $20
Current: $1.90
Upside: +952.63%
Mirum Pharmaceuticals
Nov 4, 2026
Reiterated: Buy
Price Target: $137 → $167
Current: $94.61
Upside: +76.51%
Rhythm Pharmaceuticals
Nov 4, 2026
Reiterated: Buy
Price Target: $160 → $166
Current: $112.16
Upside: +48.00%
DBV Technologies
Oct 29, 2026
Reiterated: Buy
Price Target: $55 → $47
Current: $11.88
Upside: +295.62%
Sagimet Biosciences
Oct 1, 2026
Reiterated: Buy
Price Target: $12 → $27
Current: $11.41
Upside: +136.63%
IRulya Therapeutics
Sep 22, 2026
Upgraded: Buy
Price Target: $77
Current: $38.33
Upside: +100.89%
Pharvaris
Sep 9, 2026
Reiterated: Buy
Price Target: $74 → $79
Current: $34.18
Upside: +131.13%
Protagonist Therapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $165 → $170
Current: $134.86
Upside: +26.06%
Sionna Therapeutics
Aug 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.70
Upside: -
Structure Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $113 → $110
Current: $20.95
Upside: +425.06%
Reiterated: Buy
Price Target: $9 → $7
Current: $0.6109
Upside: +1,045.85%
Initiated Coverage: Sell
Price Target: $3
Current: $4.19
Upside: -28.40%
Reiterated: Buy
Price Target: $745 → $739
Current: $433.03
Upside: +70.66%
Reiterated: Buy
Price Target: $14 → $11
Current: $1.93
Upside: +469.95%
Reiterated: Buy
Price Target: $170 → $150
Current: $46.20
Upside: +224.68%
Reiterated: Buy
Price Target: $12 → $11
Current: $4.31
Upside: +155.22%
Reiterated: Buy
Price Target: $61 → $86
Current: $57.72
Upside: +49.00%
Reiterated: Buy
Price Target: $25 → $28
Current: $7.65
Upside: +266.01%
Reiterated: Buy
Price Target: $8
Current: $1.26
Upside: +534.92%
Reiterated: Buy
Price Target: n/a
Current: $6.66
Upside: -
Reiterated: Buy
Price Target: $8 → $11
Current: $4.99
Upside: n/a
Reiterated: Buy
Price Target: $18
Current: $2.73
Upside: n/a
Reiterated: Buy
Price Target: $120 → $32
Current: $0.919
Upside: n/a
Reiterated: Buy
Price Target: $19
Current: $7.61
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $15.80
Upside: n/a
Reiterated: Buy
Price Target: $24
Current: $31.85
Upside: n/a